TABLE 4.
Multivariate logistic regression of risk factors associated with bacterial persistence in patients with ST5-/ST764-MRSA infection after vancomycin treatment
| Risk factora | Univariate analysis result OR (95% CI) |
Multivariate analysis result | |
|---|---|---|---|
| aOR (95% CI) | P valueb | ||
| Age, years | 1.009 (0.984, 1.035) | 1.003 (0.970, 1.038) | 0.860 |
| Tracheotomy | 1.700 (0.610, 4.741) | 1.058 (0.323, 3.465) | 0.926 |
| Vancomycin daily dose | 0.910 (0.417, 1.985) | 0.824 (0.296, 2.300) | 0.312 |
| AUC0-24/MIC | 1.000 (0.999, 1.002) | 1.000 (0.999, 1.001) | 0.952 |
| Biofilm | 0.709 (0.329, 1.525) | 1.044 (0.435, 2.507) | 0.923 |
| sdrE | 1.225 (0.236, 6.367) | 1.132 (0.179, 7.159) | 0.895 |
| tst | 3.359 (1.245, 9.066) | 4.509 (1.216, 16.724) | 0.024 |
| sea | 0.614 (0.123, 3.075) | 0.341 (0.061, 1.916) | 0.222 |
a
ST, sequence type; AUC0-24/MIC, 24-hour area under the curve over minimal inhibitory concentration; OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio.
b
P values< 0.05 are shown in bold.